William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), bought 125,754 shares at $16.81 ($2.1M) on 2016-09-16, disclosed to the SEC on 2016-09-16.
Open-market purchase of $2.1M ADMS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.43 | 54,537 | $896K | 43.2% |
| 2 | $16.43 | 54,537 | $896K | 43.2% |
| 3 | $16.50 | 200 | $3K | 0.2% |
| 4 | $16.81 | 8,240 | $139K | 6.7% |
| 5 | $16.81 | 8,240 | $139K | 6.7% |
| Total | $16.48 avg | 125,754 |
| $2.1M |
| 100% |
| Filing → |
| ADMS | BUY | 2016-09-14 | $2.6M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |
| ADMS | BUY | 2016-09-07 | $1.4M | — | Filing → |